Mongersen (GED-0301) for active Crohn’s disease: Results of a phase 3 study

Bruce E. Sands, Brian G. Feagan, William J. Sandborn, Stefan Schreiber, Laurent Peyrin-Biroulet, Jean Frédéric Colombel, Guillermo Rossiter, Keith Usiskin, Shabana Ather, Xiaojiang Zhan, Geert D’Haens

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Mongersen (GED-0301) for active Crohn’s disease: Results of a phase 3 study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science